In vivo effect and parallel in vitro lymphocyte-mediated tumor cytolysis after Phase I xenogeneic immune RNA treatment of patients with widespread melanoma or metastatic renal cell carcinoma.
D000230:Adenocarcinoma / Q000276:immunology / Q000628:therapy*; D004341:Drug Evaluation; D006801:Humans; D007106:Immune Sera; D007116:Immunization, Passive; D007158:Immunologic Techniques; D007680:Kidney Neoplasms / Q000276:immunology / Q000628:therapy*; D007937:Leukapheresis; D008175:Lung Neoplasms / Q000276:immunology / Q000556:secondary; D008214:Lymphocytes / Q000276:immunology*; D008545:Melanoma / Q000276:immunology / Q000628:therapy*; D009362:Neoplasm Metastasis; D012313:RNA / Q000276:immunology / Q000627:therapeutic use*
D007106:Immune Sera; D012313:RNA